The MYCN enigma: significance of MYCN expression in neuroblastoma

Cancer Research
Xao X TangNaohiko Ikegaki

Abstract

MYCN amplification strongly predicts adverse outcome of neuroblastoma. However, the significance of MYCN expression in the clinical and biological behavior of neuroblastoma has been unclear. To address this question, we first examined the expression of MYCN in combination with TrkA (a favorable prognostic indicator of neuroblastoma) in 91 primary neuroblastoma by quantitative reverse transcription-PCR and investigated the relationship among patient survival, MYCN, and TrkA expressions. Three subsets of neuroblastoma were defined based on MYCN and TrkA expression. Neuroblastoma expressing the highest level of MYCN but little TrkA were MYCN-amplified cases, which had a 5-year survival of 9.3%. Interestingly, MYCN and TrkA expression showed a linear correlation (r = 0.5664, P < 0.00005) in neuroblastoma lacking MYCN amplification, and the 5-year survival of neuroblastoma patients with low MYCN and low TrkA expressions was 63.7%, whereas those with high expression of both had a 5-year survival of 88.1% (P < 0.00005). This nonlinear distribution of disease outcome relative to MYCN expression in neuroblastoma explains why MYCN expression is not predictive of neuroblastoma disease outcome by dichotomous division of the neuroblastoma c...Continue Reading

References

Apr 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A T LookG M Brodeur
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·N IkegakiR H Kennett
Dec 21, 1988·Journal of the National Cancer Institute·P D NisenP Lanzkowsky
Oct 31, 1985·The New England Journal of Medicine·R C SeegerD Hammond
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·M SchwabJ M Bishop
Mar 25, 1993·The New England Journal of Medicine·A NakagawaraG M Brodeur
Jan 25, 1996·The New England Journal of Medicine·H CaronR Versteeg
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V CombaretM C Favrot
Jun 2, 1997·The EMBO Journal·W A WeissJ M Bishop
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S B BordowM Haber
Jun 24, 1999·The New England Journal of Medicine·N BownN Van Roy
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·X X TangN Ikegaki
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S L CohnM Haber
May 18, 2001·Nature·G I Evan, K H Vousden
Jul 24, 2001·Medical and Pediatric Oncology·X X TangN Ikegaki
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Loen M HansfordGlenn M Marshall
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xao X TangNaohiko Ikegaki
Jul 28, 2005·Pediatric Blood & Cancer·Miguel AlaminosNai-Kong V Cheung
Aug 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Giovanni PeriniGiuliano Della Valle
Nov 25, 2005·The New England Journal of Medicine·Edward F AttiyehUNKNOWN Children's Oncology Group

❮ Previous
Next ❯

Citations

Aug 28, 2007·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·V CastelF Martínez
Jan 27, 2010·Oncogene·W C Gustafson, W A Weiss
Sep 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Erik FredlundSven Påhlman
Jul 21, 2009·BMC Cancer·Joannes F M JacobsArjan P M de Brouwer
Feb 10, 2007·FEBS Letters·Stefano AmenteBarbara Majello
Feb 16, 2010·Cancer Letters·Emma BellDeborah A Tweddle
Jun 26, 2007·Lancet·John M MarisSusan L Cohn
Jul 6, 2007·Cancer Letters·Raffaella DefferrariKatia Mazzocco
Mar 12, 2009·Journal of Cellular Biochemistry·Lars M Wagner, Mary K Danks
Jul 29, 2011·International Journal of Cancer. Journal International Du Cancer·Sara De BrouwerFrank Speleman
Aug 28, 2009·International Journal of Cancer. Journal International Du Cancer·Dietmar AbrahamSeyedhossein Aharinejad
Dec 5, 2009·International Journal of Cancer. Journal International Du Cancer·Dirk GeertsAndré S Bachmann
Aug 20, 2015·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Sagar ShelakeRiyaz Basha
Oct 16, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yaqiong JinYongli Guo
Oct 19, 2017·Pediatric Hematology and Oncology·Panagiotis KratimenosStamatios Theocharis
Feb 27, 2010·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Rosa NogueraAntonio Llombart-Bosch
May 1, 2013·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Imane TabyaouiSoumaya Zamiati
Jun 23, 2018·Oncotarget·Paola BettinsoliMaurizio Memo
Feb 23, 2020·International Journal of Molecular Sciences·Monica CurròRiccardo Ientile
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexander SchrammAngelika Eggert
Dec 22, 2010·Molecular Cancer Research : MCR·Marialaura PetroniGiuseppe Giannini
Sep 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jesmin AkterAkira Nakagawara

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis